PR Newswire BiotechOriginal article
Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio
Partnershipproprietary peptide portfolioPositive
AI Analysis
Summary
Vector Science & Therapeutics announced an exclusive cGMP manufacturing agreement with LyoGenesis Plus, licensing its proprietary biomechanical peptide delivery platform in exchange for long-term manufacturing services for its peptide portfolio.
Outcome Details
Exclusive cGMP manufacturing agreement with long-term manufacturing relationship
Importance:6/10
Sentiment:
0.60
partnershipmanufacturinglicensingpeptidecGMP
Read the original article
Published by PR Newswire Biotech on July 7, 2026 11:50 AM